Phase II study of radical hysterecotmy and perioperative chemotherpy with Docetaxel and Carboplatin for cervical cancer

Phase 2

Recruiting

• Conditions: Cervical cancer

• Registration Number: JPRN-UMIN000017808
• Lead Sponsor: Saitama Medical university International Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-06-05
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

1. Having fever more than 38.0 degrees 2. Active serious systemic disease, including active bacterial or fungal infection. 3. Clinically siginificant heart disease or other complications. 4. Evidence of other active invasive malignancy. 5. Previous treatment with Taxens and/or Platinums. 6. Any medical or other condition that, in the opinion of the investigator, would preclude the subjects' participation in a clinical study including medical contraindications.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
disease free survival